Climb Bio, Inc. (CLYM)
CLYM Stock Price Chart
Explore Climb Bio, Inc. interactive price chart. Choose custom timeframes to analyze CLYM price movements and trends.
CLYM Company Profile
Discover essential business fundamentals and corporate details for Climb Bio, Inc. (CLYM) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
—
Employees
17.00
Website
https://eliemtx.comCEO
Aoife M. Brennan BAO, BCh, MB, MMSc
Description
Climb Bio, Inc., a biotechnology company, focuses on developing therapies for autoimmune-driven inflammatory diseases. It develops budoprutug, an anti-CD19 monoclonal antibody for various autoimmune diseases, including systemic lupus erythematosus and lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The company was formerly known as Eliem Therapeutics, Inc. and changed its name to Climb Bio, Inc. in October 2024. Climb Bio, Inc. was incorporated in 2018 and is headquartered in Wilmington, Delaware.
CLYM Financial Timeline
Browse a chronological timeline of Climb Bio, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.17.
Earnings released on 12 Aug 2025
EPS came in at -$0.13 surpassing the estimated -$0.19 by +31.58%.
Earnings released on 14 May 2025
EPS came in at -$0.31 falling short of the estimated -$0.15 by -106.67%.
Earnings released on 25 Mar 2025
EPS came in at -$0.13 surpassing the estimated -$0.15 by +13.33%.
Earnings released on 12 Nov 2024
EPS came in at -$0.13 .
Earnings released on 14 Aug 2024
EPS came in at -$1.81 .
Earnings released on 15 May 2024
EPS came in at -$0.06 .
Earnings released on 31 Dec 2023
EPS came in at -$0.13 falling short of the estimated -$0.13 by -2.55%.
Earnings released on 30 Sept 2023
EPS came in at -$0.15 falling short of the estimated -$0.14 by -4.70%.
Earnings released on 30 Jun 2023
EPS came in at -$0.19 falling short of the estimated -$0.16 by -21.55%.
Earnings released on 31 Mar 2023
EPS came in at -$0.84 falling short of the estimated -$0.25 by -236.00%.
Earnings released on 31 Dec 2022
EPS came in at -$0.29 surpassing the estimated -$0.38 by +22.55%.
Earnings released on 30 Sept 2022
EPS came in at -$0.37 .
Earnings released on 30 Jun 2022
EPS came in at -$0.56 falling short of the estimated -$0.43 by -28.34%.
Earnings released on 31 Mar 2022
EPS came in at -$0.50 .
Earnings released on 31 Dec 2021
EPS came in at -$0.40 .
Earnings released on 30 Sept 2021
EPS came in at -$0.62 .
Earnings released on 30 Jun 2021
EPS came in at -$0.37 .
Earnings released on 31 Mar 2021
EPS came in at -$1.60 .
Earnings released on 31 Dec 2020
EPS came in at -$0.44 .
Earnings released on 30 Sept 2020
EPS came in at -$0.19 .
CLYM Stock Performance
Access detailed CLYM performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.